Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report

Long-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we describe a case of acute visual impairment after Pfizer-BioNTech vaccine second dose. 

Detalles Bibliográficos
Autores principales: Santovito, Luca Spiro, Pinna, Graziano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176659/
https://www.ncbi.nlm.nih.gov/pubmed/34086060
http://dx.doi.org/10.1007/s00011-021-01476-9
_version_ 1783703290323664896
author Santovito, Luca Spiro
Pinna, Graziano
author_facet Santovito, Luca Spiro
Pinna, Graziano
author_sort Santovito, Luca Spiro
collection PubMed
description Long-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we describe a case of acute visual impairment after Pfizer-BioNTech vaccine second dose. 
format Online
Article
Text
id pubmed-8176659
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-81766592021-06-04 Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report Santovito, Luca Spiro Pinna, Graziano Inflamm Res Letter to the Editor Long-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we describe a case of acute visual impairment after Pfizer-BioNTech vaccine second dose.  Springer International Publishing 2021-06-04 2021 /pmc/articles/PMC8176659/ /pubmed/34086060 http://dx.doi.org/10.1007/s00011-021-01476-9 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter to the Editor
Santovito, Luca Spiro
Pinna, Graziano
Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
title Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
title_full Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
title_fullStr Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
title_full_unstemmed Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
title_short Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report
title_sort acute reduction of visual acuity and visual field after pfizer-biontech covid-19 vaccine 2nd dose: a case report
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176659/
https://www.ncbi.nlm.nih.gov/pubmed/34086060
http://dx.doi.org/10.1007/s00011-021-01476-9
work_keys_str_mv AT santovitolucaspiro acutereductionofvisualacuityandvisualfieldafterpfizerbiontechcovid19vaccine2nddoseacasereport
AT pinnagraziano acutereductionofvisualacuityandvisualfieldafterpfizerbiontechcovid19vaccine2nddoseacasereport

Ejemplares similares